For CounterPunch, Martha Rosenberg and Ronnie Cummins comment on the announcement that Bayer has placed a bid to buy Monsanto. “Bayer and Monsanto both sell controversial toxic agricultural chemicals and GMO seeds,” they write. “But if Bayer’s bid to take over Monsanto goes through, it would mark Monsanto’s first entry into Big Pharma.”
